Edition:
United Kingdom

Abbott Laboratories (ABT.N)

ABT.N on New York Stock Exchange

68.79USD
20 Sep 2018
Change (% chg)

$0.29 (+0.42%)
Prev Close
$68.50
Open
$68.63
Day's High
$69.01
Day's Low
$68.40
Volume
1,384,079
Avg. Vol
1,446,354
52-wk High
$69.01
52-wk Low
$51.38

Latest Key Developments (Source: Significant Developments)

Abbott's Freestyle Libre 14 Day Flash System Approved In U.S.
Friday, 27 Jul 2018 

July 27 (Reuters) - Abbott Laboratories ::ABBOTT'S FREESTYLE® LIBRE 14 DAY FLASH GLUCOSE MONITORING SYSTEM NOW APPROVED IN U.S..ABBOTT -FREESTYLE LIBRE 14 DAY SYSTEM TO BE AVAILABLE VIA PRESCRIPTION IN COMING MONTHS AT PARTICIPATING PHARMACIES, DMES IN U.S..  Full Article

Abbott Begins U.S. Pivotal Trial For Tendyne Mitral Valve Replacement System
Thursday, 26 Jul 2018 

July 26 (Reuters) - Abbott Laboratories ::ABBOTT BEGINS U.S. PIVOTAL TRIAL FOR THE TENDYNE MITRAL VALVE REPLACEMENT SYSTEM TO TREAT PATIENTS WITH HEART VALVE DISEASE.  Full Article

ViewRay Appoints Scott Drake As Chief Executive Officer
Tuesday, 24 Jul 2018 

July 24 (Reuters) - ViewRay Inc ::VIEWRAY APPOINTS SCOTT DRAKE AS PRESIDENT, CHIEF EXECUTIVE OFFICER AND A MEMBER OF THE BOARD OF DIRECTORS, SHAR MATIN AS CHIEF OPERATING OFFICER, AND D. KEITH GROSSMAN AS A MEMBER OF THE BOARD OF DIRECTORS.VIEWRAY INC - VIEWRAY PRE-RELEASES PRELIMINARY Q2 2018 REVENUE OF $16 MILLION AND REAFFIRMS REVENUE GUIDANCE OF $80 TO $90 MILLION FOR 2018.VIEWRAY INC - ANNOUNCED DEPARTURES OF CURRENT PRESIDENT AND CHIEF EXECUTIVE OFFICER CHRIS A. RAANES.  Full Article

FDA Says Tibsovo's Prescribing Information Includes Boxed Warning Regarding Differentiation Syndrome
Friday, 20 Jul 2018 

July 20 (Reuters) - U.S. Food and Drug Administration::FDA SAYS TIBSOVO'S PRESCRIBING INFORMATION INCLUDES BOXED WARNING THAT A POTENTIALLY FATAL ADVERSE REACTION KNOWN AS DIFFERENTIATION SYNDROME CAN OCCUR.  Full Article

Abbott Laboratories Says Redeemed $1.3 Bln Of $1.8 Bln Outstanding Aggregate Principal Amount Of 2.35% Notes
Friday, 22 Jun 2018 

June 22 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS REDEEMED $1.30 BILLION OF $1.80 BILLION OUTSTANDING AGGREGATE PRINCIPAL AMOUNT OF ITS 2.350% NOTES DUE 2019 - SEC FILING.  Full Article

Abbott Laboratories Says Launched Its Afinion 2 Analyzer In U.S.
Thursday, 31 May 2018 

May 31 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - LAUNCH OF ITS AFINION 2 ANALYZER IN U.S..  Full Article

Abbott Laboratories Says Shareholders Rejected Proposal Requesting Board Of Directors Adopt Policy That Board Chairman Be Independent Director
Monday, 30 Apr 2018 

April 30 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES SAYS SHAREHOLDERS REJECTED PROPOSAL REQUESTING CO'S BOARD OF DIRECTORS ADOPT POLICY THAT BOARD CHAIRMAN BE INDEPENDENT DIRECTOR.  Full Article

Abbott Laboratories - Co, Sanquin Sign Multiple-Year Contract For Supply Of Primary Serological Equipment And Consumables
Monday, 23 Apr 2018 

April 23 (Reuters) - Abbott Laboratories ::ABBOTT LABORATORIES - CO, SANQUIN SIGN MULTIPLE-YEAR CONTRACT FOR SUPPLY OF PRIMARY SEROLOGICAL EQUIPMENT AND CONSUMABLES.  Full Article

Abbott Initiates Groundbreaking Study To Assess Superiority Of High-Resolution Imaging Versus Standard-Of Care Angiography In Treating Coronary Artery Disease
Wednesday, 11 Apr 2018 

April 11 (Reuters) - Abbott Laboratories ::CARE ANGIOGRAPHY IN TREATING CORONARY ARTERY DISEASE.RESOLUTION IMAGING RESULT IN LARGER VESSEL DIAMETERS.  Full Article

Mylan To Complete $1 Billion Share Repurchase Plan
Monday, 8 Jan 2018 

Jan 8 (Reuters) - Mylan Nv ::MYLAN TO COMPLETE $1 BILLION SHARE REPURCHASE PLAN.MYLAN - AS PER AGREEMENT WITH ABBOTT RELATED TO ABBOTT EPD DEAL, ABBOTT NOTIFIED MYLAN IT SOLD REMAINING 20.3 MILLION IN MYLAN SHARES PRIOR TO YEAR-END​.  Full Article

Photo

Exclusive: India, U.S. closing in on package deal to remove trade irritants

NEW DELHI Indian farmers and U.S. manufacturers of medical devices could be among the main winners in a trade package under negotiation, as Washington and New Delhi look to remove long-standing irritants to ties, sources familiar with the talks said.